Ophthalmology

Top Story

BLOG: Is fluorometholone the magic mucin medicine?

June 25, 2019

Aldeyra to stop noninfectious anterior uveitis program

June 25, 2019
Aldeyra intends to discontinue its noninfectious anterior uveitis program after no primary or secondary endpoints were achieved in the SOLACE trial. According to a…
Perspective

AbbVie to acquire Allergan for $63 billion

June 25, 2019
Allergan will be acquired by AbbVie for approximately $63 billion in cash and stock, the two companies announced in a press release. Under a definitive transaction…

OCTANe’s Ophthalmology Technology Summit fosters business, collaborations

June 25, 2019
OCTANe’s sixth annual Ophthalmology Technology Summit will feature presentations from four LaunchPad SBDC companies, according to a press release. Cell Care…
In the Journals

Optimal dose of potential IOP-lowering agent demonstrated

June 24, 2019
Three randomized, multicenter, phase 2 studies demonstrated the efficacy and safety of omidenepag isopropyl as an alternative method to lower IOP, according to a study. …
More Headlines »
Clinical Science

Three-Year Findings on Intraocular Pressure Changes in The Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study

Ophthalmic Surgery, Lasers and Imaging Retina, June 2019, Volume 50 Issue 6
This paper reports 3-year intraocular pressure (IOP) outcomes of the Prospective Retinal and Optic Nerve Vitrectomy…
More »
CME

When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR—A Woman With Longstanding Diabetes Presents With Decreased Vision

This activity is provided by Global Education Group.

Explore the treatment options for a patient with longstanding diabetes and decreased vision presented by Dr Arshad…
More »
Resource Centers
Kiawah Eye Meeting

Kiawah Eye Meeting

Video
Meeting News

VIDEO: Intraoperative OCT study finds no correlation between axial length, lens thickness

June 9, 2019
More »